Shengjing Hospital
Shenyang, Liaoning, 110004, China
NCT Number: NCT03186079
Constipation is the most common complaint in childhood gastrointestinal disease,affecting an estimated 20% of the global children.The treatment strategies consist of diet control,behavioural intervention and oral and sometimes rectal laxatives. Given higher success rate and fewer side effects,the laxative PEG3350 has been considered the first choice in childhood constipation.However, effectiveness of PEG 3350 laxative is not lasting, additional treatment interventions are still necessary.With an unsatisfactory response to current treatments, many patients seek help from Chinese Herbal Medicine.In view of the traditional theory, childhood constipation is derived from weakness of gastric and splenic function.The functional weakness is characterized by food stagnation and further pathological heat accumulation in the gastrointestine. The food stagnation can slow the gastrointestinal motility while heat causes constipation by drying the intestines and their content. Therefore, the therapeutic principles and practices for childhood constipation must focus on the pathophysiological basis accordingly. In the documented traditional medicine dictionary(Pi Wei Lun), Xiaojidaozhi Decoction is well described in improving the gastric and splenic function, eliminating food stagnation and removing pathological heat accumulation, and it has always been used in treatment of constipation throughout Asia since the first description in Pi Wei Lun in 1249. It comprises twelve herbs. Through the combined action of these herbs, Xiaojidaozhi Decoction can increase fluid in the intestines and facilitate the gastrointestinal motility, relieving the symptoms of constipation. Despite of the long history of successful use of Xiaojidaozhi Decoction in childhood constipation, a large randomized placebo-controlled trial is still not available.The aim of this study was to explore the clinical efficacy and safety of Chinese herbal medicine Xiaojidaozhi Decoction in the treatment of childhood constipation.
Looking for future studies?
Notify Me4 year–14 year
All sexes
Interventional
Early Phase 1
Shenyang, Liaoning, 110004, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mixture of twelve Chinese herbal medicines granule
Other names: XJD
Mixture of 10% Chinese herbal medicines granule and 90% artificial gum
Other names: Placebos
Fiberform is a low-phytate wheat fibre which can increase the gastrointestinal motility.
Toilet training has been considered a routine method in treatment of constipation
Time frame: week 8(end of treatment)
Efficacy is ranked as cured, improved, same/worse
Time frame: week 20(end of follow-up)
Efficacy is ranked as cured, improved, same/worse
Time frame: beginning of treatment(baseline)
Constipation is evaluated and scored on the related symptoms of stool frequency, appearance,consistency and incontinence
Time frame: week 8(end of treatment)
Constipation is evaluated and scored on the related symptoms of stool frequency, appearance,consistency and incontinence
Time frame: week 20(end of follow-up)
Constipation is evaluated and scored on the related symptoms of stool frequency, appearance,consistency and incontinence
Time frame: Within week 20(end of follow-up)
The adverse events reported in treatment
Shengjing Hospital
Other
Efficacy of Chinese Herbal Medicine Xiaojidaozhi Decoction in the Treatment of Childhood Functional Constipation: a Double Blind, Randomized and Placebo-controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04068415
Constipation, Pathological Conditions, Signs and Symptoms
View Trial DetailsNCT04666155
Constipation, Constipation - Functional
Durham, County Durham and Darlington, United Kingdom
View Trial DetailsNCT06311097
Constipation, Healthy
Copenhagen, Denmark
View Trial DetailsNCT07230821
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Del Mar, California, United States
View Trial Details